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Background: A program supporting the initiation of insulin therapy in primary care was introduced in Belgium, as
part of a larger quality improvement project on diabetes care. This paper reports on a study exploring factors
influencing the engagement of general practitioners (GPs) in insulin therapy initiation (research question 1) and
exploring factors relevant for future program development (research question 2).
Methods: We have used semi-structured interviews to answer the first research question: two focus group interviews
with GPs who had at least one patient in the insulin initiation program and 20 one-to-one interviews with GPs who
were not regular users of the overall support program in the region. To explore factors relevant for future program
development, the data from the GPs were triangulated with data obtained from individual interviews with patients
(n = 10), the diabetes nurse educator (DNE) and the specialist involved in the program, and data extracted from
meeting reports evaluating the insulin initiation support program.
Results: We found differences between GPs engaged and those not engaged in insulin initiation in attitude,
subjective norm and perceived behavioural control regarding insulin initiation. In general the support program was
evaluated in a positive way by users of the program. Some aspects need further consideration: job boundaries
between the DNE and GPs, job boundaries between GPs and specialists, protocol adherence and limited case load.
Conclusion: The study shows that the transition of insulin initiation from secondary care to the primary care setting is
a challenge. Although a support program addressing known barriers to insulin initiation was provided, a substantial
number of GPs were reluctant to engage in this aspect of care. Important issues for future program development are:
an interdisciplinary approach to job clarification, a dynamic approach to the integration of expertise in primary care
and feedback on protocol adherence.
Trial registration: ClinicalTrials.gov Identifier: NCT00824499
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Type 2 diabetes (T2DM) is characterized by both insulin
resistance and inadequate insulin secretion. As T2DM is
a progressive disease many patients require insulin ther-
apy at some point in time [1]. The number of T2DM
patients on insulin therapy is rising due to the increasing
prevalence of T2DM, the more stringent glycaemic targets* Correspondence: patricia.sunaert@ugent.be
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unless otherwise stated.and improved life expectancy among T2DM patients. In
2004 396,481 persons in Belgium were reimbursed at least
one package of diabetes medication of whom 104,780
were prescribed insulin therapy; in 2010 this was respect-
ively 489,559 and 136,753 [2].
Although insulin therapy is no longer a secondary care
based activity in countries like the United Kingdom
(UK) and the Netherlands, the involvement of general
practitioners (GPs) is still limited in many other coun-
tries [3-5]. There is no evidence that the outcomes of in-
sulin therapy are different when managed in primaryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Multifaceted support program addressing known
barriers to insulin initiation
Addressing patient barriers: misconceptions about insulin therapy,
fear of injections, fear of hypoglycaemia, fear that insulin therapy
will interfere with daily living, social stigma
• Structured education program: patient education checklist addressing
potential barriers and misconceptions, familiarising with what insulin
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pragmatic reasons to involve primary care in insulin
therapy. First of all, many T2DM patients have more
than one chronic condition and will benefit from a holis-
tic approach [6,7]. Further, it is expected that involve-
ment of primary care in insulin therapy will decrease the
delay in treatment intensification. Furthermore, there
are simple insulin regimens that are easy to start within
primary care [8].
GPs in Belgium are encouraged to take up a more
active role in insulin therapy since the introduction of
a care pathway T2DM by the National Institute for
Health and Disability Insurance (NIHDI) [9]. This paper
reports the findings of a study we performed before the
introduction of the care pathway T2DM in 2009. In this
study we explored ways to improve care delivery for
T2DM patients using a complex intervention targeting all
T2DM patients and their care providers in a well-defined
geographical region in Belgium (2003–2007) [10].
One of the interventions was the introduction of a
support program for insulin initiation in primary care.
At the end of the study period 56% (response rate 80%)
of the GPs reported starting insulin therapy in practice,
33% of the GPs in the region had at least one patient in
the program (unpublished data).
This paper reports on a study evaluating the support
program at the end of the study period.
The paper addresses the following research questions:
1. Which factors influenced the engagement of GPs in
insulin initiation?
2. What lessons can be learned for future program
development?is, guiding on when and who to call for problems, .…
• Educational tools for patients: information sheets regarding SMBG,
insulin administration, managing hypoglycemia; patient booklet;
website [www.diabetesprojectaalst.be]
• SMBG-material for free; devices corresponding with patient’s needs
and capabilities.
Addressing physician barriers: doubts about the benefit of insulin
therapy, lack of knowledge, lack of familiarity, concerns about theMethods
Design
A qualitative study exploring factors influencing the en-
gagement of GPs in insulin initiation in a context where
a support program is provided and exploring factors
relevant for future program development.risk of hypoglycaemia, concerns about patient compliance, time
constraints, lack of staff support
• Simplified treatment protocol starting with a once-daily insulin
regime.
• Provider education: interactive workshops (main topics: indications for
insulin therapy in T2DM, starting up a once daily basal insulin
regimen, insulin titration algorithm and collaboration modalities,
website (www.diabetesprojectaalst.be), continuous feedback by DNE.
• Coaching of GPs by specialists from the 2 hospital diabetes centres
(e-mail, phone).
• Team-working approach: interdisciplinary protocol with clear job
descriptions.
• Appointment of a well-trained diabetes nurse educator (DNE).
• Formal mentoring of DNE by one of the specialists from the region.Setting
The region counted 83 GPs (of whom 70% worked in a
single-handed practice) for 76,826 inhabitants and two
hospital based diabetes centres. Since 1987, hospitals in
Belgium are financed by NIHDI to establish multidiscip-
linary diabetes centres. In these centres patients receive
care from a diabetes team (diabetologist, diabetes nurse
educator (DNE) and dietician) and obtain material for
self-monitoring of blood glucose (SMBG) for free [11].
At the start of the study most GPs referred their patients
to one of the two hospital diabetes centres once insulin
was required.Characteristics of the support program
We developed a multifaceted support program address-
ing the main barriers to insulin initiation reported in
the literature (Table 1) [12-15]. Participation of care pro-
viders (DNE, GPs, specialists, certified diabetes nurses
(home nursing)) was solicited by means of study groups
with the aim of translating the program to the local con-
text [16]. This process resulted in an interdisciplinary
protocol (www.diabetesprojectaalst.be). GPs were assigned
a central role in the management of patients eligible for a
once-daily insulin regimen. Starting up a basal insulin
regimen represents a simple and effective way to start in-
sulin therapy [8]. Once patients required a more complex
scheme, referral to secondary care was advised. GPs were
expected to discuss the option of insulin therapy with
their patients when oral therapy failed (indication, bene-
fits, and barriers) and to take care of the follow-up. Fur-
thermore, GPs were advised to refer their patients to a
DNE once insulin therapy was considered. During the
study a well-trained DNE was engaged who operated from
a community diabetes centre in the region. Less mobile
patients were instructed at home. The service was free of
charge for the patients and the DNE was paid a wage
(breaking up with the usual fee-for-service system in the
Belgian context). As such a flexible program, meeting the
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ceived SMBG material for free. Certified diabetes nurses
were involved when patients needed (temporarily) support
at home for administering insulin injections. Specialists
were expected to coach the GPs, the DNE and home
nurses. One specialist (FN) invested on average 4 hours a
month to supervise the content of the program and to
coach the DNE. To enhance self-confidence among GPs
we organized two interactive workshops, one at the start of
the study, and another one six months later, to familiarize
with the proposed insulin regimen.
Data collection
We used semi-structured interviews to answer the first
research question: two focus group interviews with GPs
who had at least one patient in the insulin initiation pro-
gram and 20 one-to-one interviews with GPs who were
not regular users of the overall support program in the
region. In order to explore factors relevant for future
program development, the data from the GPs were tri-
angulated with data obtained from one-to-one interviews
with patients (n = 10), the DNE and the specialist in-
volved in the program development, and data extracted
from meeting reports evaluating the insulin initiation
support program. All data were collected according to
standardized procedures [17,18].
GPs who had at least one patient in the insulin initi-
ation program during the first study year (n = 13) were
invited to take part in a focus group meeting. Two GPs
refused to participate, one because of time constraint,
another because the interview was planned during the
evening hours. Two GPs called off at the last moment
for reasons of occupational activities (too busy in prac-
tice). A purposive sample of 20 GPs (degree of participa-
tion in the overall program, gender, age, practice type)
was selected for one-to-one interviews. Five could not
be interviewed: four GPs refused (two because of time
constraint, two without a formal reason and one GP was
abroad when the interviews were planned). They were
replaced by GPs with a comparable profile. Patients who
were initiated insulin therapy in the first study year and
had a follow-up of at least one year in the community
diabetes centre (n = 14) were eligible for the one-to-one
interviews. Four could not be interviewed; one because
of cognitive deterioration, three refused without a formal
reason.
The focus group interviews were moderated (PS) and ob-
served (LF) by members of the research team (Department
of General Practice and Primary Health Care, Ghent
University). Participating GPs knew both researchers
from meetings in the region. The DNE participated in
the focus group interviews in order to clarify some aspects
of the support program. The one-to-one interviews (pa-
tients and GPs) were conducted by a trained interviewer(psychologist- MV) who was familiar with the program
and the interview aims but was not involved in the pro-
gram. Verbal informed consent was obtained from all
interview participants. All participants were informed
about the purpose of the interviews (evaluation of partici-
pants’ experiences with the introduction of a new service
in the region) at the time of the invitation and at the start
of the interview.
Focus group interviews and one-to-one interviews with
patients took place at the community diabetes centre.
One-to-one interviews with GPs took place at the GP’s
practice. All interviews were audiotaped and transcribed
verbatim. Data extraction from meeting reports was per-
formed by PS.
Data analysis
Data analysis of the different data sources followed the
principles of content analysis and constant comparison
and was guided by the research questions [19]. Data
management was undertaken manually. In order to
organize the data relevant for the first research question
the theory of planned behaviour (TPB) was used [20].
This social cognition model has been widely used to pre-
dict individual behaviours, and has been one of the the-
ories used most often when exploring determinants of
professional behaviour. The theory states that an individ-
ual’s intention to perform a behaviour is the proximal
predictor of behaviour. In turn intention is predicted by
attitude (the degree to which a person has a favorable or
unfavorable evaluation or appraisal of the behaviour in
question), subjective norm (the perceived social pressure
to perform or not to perform the behaviour) and per-
ceived behavioural control (the perceived ease or diffi-
culty of performing the behaviour).
Two researchers (LF, PS) performed the triangulation
process guided by the triangulation protocol of Farmer to
answer research question 2 [21]. Both researchers first an-
alyzed the data independently (sorting, convergence cod-
ing, convergence assessment, completeness assessment).
Next, consensus on the key themes emerging from the
data was reached through discussion (researcher compari-
son). A summary of the triangulated results was sent for
review to the members of the local steering group in the
region. They agreed with the results.
Ethical considerations
The study was approved by the Ethics Committee of the
University of Ghent (Approval number 2004/253) and
the Ethics Committee of the University of Antwerp
(Approval number 12/07/2004).
Results
Table 2 gives a summary of the characteristics of the inter-
view participants.
Table 2 Background data of the interview participants
Focus group interviews
with GPs (n = 9)
Mean age (SD): 50,8 (10,1; 31–68)
[<40 years: 1; 40–50 years 3;
50–60 years: 4; > 60 years:1]
Female: 1
Single-handed practice: 5
One-to-one interviews
with GPs (n = 20)
Mean age (SD): 48,2 (9,2; 31–65)
[<40 years: 3; 40–50 years: 8;
50–60 years: 7; > 60 years:2]
Female: 4
Single-handed practice: 17
One-to-one interviews
with patients (n = 10)
Mean age (SD): 67,1 (10,8; 54–82)
[50–60 years: 3; 60–70 years: 2;
>70 years 5]
Female: 3
Diabetes duration (SD): 11,7 (6,4; 5–25)
HbA1c% (SD): 9,4* (1,3; 7,6-11,7);
*79 mmmol/mol
Figure 1 Quotes in relation to GPs’ engagement in insulin initiation (
Sunaert et al. BMC Family Practice 2014, 15:144 Page 4 of 9
http://www.biomedcentral.com/1471-2296/15/144Factors influencing the engagement in insulin initiation
(research question 1)
We found differences between GPs engaged and those
not engaged in insulin initiation in attitude, subjective
norm and perceived behavioural control regarding insulin
initiation. The findings are illustrated with some quotes
in Figure 1.
Attitude
For some GPs the transition of insulin initiation to the pri-
mary care setting increased job satisfaction. They were
eager to be involved and their engagement was reinforced
by the positive feedback of their patients. Others appreci-
ated the opportunity to start insulin therapy for some pa-
tient groups, e.g. the elderly. Their engagement depended
on the complexity of the case and the choice of the pa-
tients. Some GPs felt no need for change. Most of them
expected no added value (for themselves or their patients)
of being involved in insulin initiation. On the contrary,
they perceived this aspect of care as too demanding. TheyTPB).
Table 3 Main themes and subthemes in relation to future
program development
Aspects related to program satisfaction
Patient views ‘It is easier to start in primary care. Our
GP lives across the street. He’s known us
for years.’ (interview patients; P2) ‘The
DNE has the time to give us information.
She explained everything to me; why I
have to use insulin, how I should use it,
… it is really nice.’ (interview patients; P
3) “They” (DNE, GP) work together very
well. On one occasion my results were
not good. The DNE phoned my GP and
they agreed on changing my therapy.’
(interview patients; P 9)
- GP is in charge
- information
- emotional support
- time
- flexibility
- free of charge
- collaboration between
DNE and GP
GP views ‘The workshop was very good. The
information was to the point, very clear.’
(focus group; GP 2) ‘Formost patients
insulin therapy is still the last thing theywant
to start with. They have no problemswith
an extra tablet, but starting insulin therapy is
still an enormous threshold to overcome.
Although, once they are on insulinmost of
themhave no problemwith it.’ (focus
group; GP 9) ‘The DNE has the
competence and the time to give
information to the patient. When we
engage ourselves in insulin therapy, we
have to do it well. With the support of the
DNE I feel comfortable.’ (focus group GP 8)
- information in workshops
- protocol
- support in primary care
- overcoming patients’
barriers
- patients are satisfied
- structured approach
by DNE
- communication with DNE
- coaching by the specialist
Aspects for consideration in future program development
Job boundaries between
DNE and GPs
‘We were not used to this kind of service in
primary care. We need time to learn how
we can work together.’ (focus group; GP
3) ‘I see my patient every three months. In
between the DNE is responsible for
adjusting insulin doses. She communicates
with the patient regarding this topic. I feel
relieved that I can delegate this job to her.’
(focus group; GP 4)
- new function in primary
care
- fear to lose the patient
- control over therapy
- limited tradition of
collaboration
Job boundaries between
GPs and specialists
‘Patients in the program receive the advice
to consult the specialist once they require
two or more injections a day. This has
prevented me from referring patients to
the support program.’(one-to-one
interview; GP 3)
- limitation to once daily
insulin regimen
- engagement of specialists
Protocol adherence ‘When insulin therapy is initiated, patients
always do more measurements. There is
’the fear of hypoglycaemia’. I suppose this
is normal.’ (focus group, GP 8) ‘I like to
have a glycaemic value during the day. It
reassures me.‘ (focus group; GP 1)
- postponement of dose
titration
- fear of hypoglycaemia
- treating the regimen as
a complex one
- limited engagement of
patients in dose adjustment
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lin therapy was required and did not intend to change
their habits.
Subjective norm
Some GPs perceived the transition of insulin initiation
to the primary care setting as an acknowledgment by
health policy of their role in diabetes care. The feeling of
recognition of their role in diabetes care was reinforced
by the positive attitude of specialists regarding the pro-
gram. Others were suspicious regarding the outcome of
the study and the motives of health policy. They did not
believe that specialists would agree with the transition of
this aspect of care to the primary care setting. For this
reason they did not engage in the program.
Perceived behavioural control
For some GPs, the launch of the program was the im-
petus to take up this aspect of care. They appreciated
the opportunities to become more knowledgeable re-
garding insulin initiation. The support program gave
them the confidence to engage in insulin initiation. As a
result they stressed on the importance of the continuity
of the program for their involvement in insulin initi-
ation. However, a substantial number of GPs remained
insecure regarding insulin initiation. In particular, the
increasing complexity of insulin regimens made some
GPs reluctant to engage in insulin therapy. Most of
them did not attend the workshops since they did not in-
tend to engage in insulin initiation. Further, the risk for
hypoglycaemia was an important reason why some GPs
perceived this aspect of care as too risky to be involved in.
They felt not well enough equipped in comparison with
specialists to handle this problem.
Factors relevant for future program development
(research question 2)
In general the support program was evaluated in a posi-
tive way by users of the program (patients and GPs).
The main aspects related to program satisfaction are dis-
cussed and illustrated with some quotes (Table 3). Some
aspects need to be taken into account in future program
developments: job boundaries between the DNE and GPs,
job boundaries between GPs and specialists and protocol
adherence.
Aspects related to program satisfaction
Patient views
Patients were very positive regarding the offer and hoped
the program would continue in the future. They appreci-
ated the fact that they could be helped in primary care
and some mentioned that the opportunity to start insulin
therapy with their GP decreased the threshold to insulin
therapy. Most patients expressed that the transition toinsulin therapy was a difficult step to take and that the
DNE helped them with making this transition. Some pa-
tients especially valued the emotional support and the
possibility to have an extra session if needed (flexibility of
the offer). The fact that the service (education, SMBG-
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patients. The close collaboration between the DNE and
the GP enhanced patients’ confidence in the program.
GP views
GPs valued the information given in the workshops and
the opportunity for feedback from the DNE and the spe-
cialists. All GPs evaluated the support by the DNE in a
positive way. Most GPs reported that patients try to
postpone insulin therapy as long as possible. GPs experi-
enced that the DNE was able to overcome barriers in
most cases. Some GPs experienced that gaining more
confidence in insulin therapy had also a positive effect
on patients’ perception of insulin therapy.
Aspects for further consideration
Job boundaries between GPs and the DNE
Since the DNE was a new job in primary care, uncer-
tainty about job boundaries rose among GPs. Some GPs
feared further fragmentation of care and losing control
over therapy. However, once they had a patient in the pro-
gram most GPs valued the specific competence of the
DNE. Gradually, the role of the DNE evolved to an expert
role and GPs could rely on her advice for patient related
problems. The DNE noticed that she often had to take the
initiative for consultation (questionnaire DNE, meeting re-
ports). GPs acknowledged this and remarked they needed
time to get used to this kind of service.
Some uncertainty remained regarding the responsibil-
ity for the adjustment of insulin doses. Some GPs - often
the most experienced ones - were happy to delegate this
job to the DNE. Others preferred to keep control of this
part of the job and made arrangements with patients, e.
g. a phone call every week.
The DNE tried to overcome uncertainty regarding job
boundaries by consulting GPs on a regular basis (e-mail,
phone), e.g. asking for consent before adjusting insulin
therapy. Although GPs appreciated this way of working
it is probably not feasible to continue this strategy when
the workload increases (questionnaire DNE, meeting re-
ports). The DNE emphasized that, in order to take up an
expert role in the future, it is crucial that the case load for
a DNE is high enough and that opportunities for continu-
ous education are provided (questionnaire DNE).
Job boundaries between GPs and specialists
The readiness to involve GPs in insulin therapy varied
among specialists in the region. Some specialists hesi-
tated to engage GPs in insulin therapy, others referred
patients (eligible for a once-daily insulin regimen) back
to primary care. Since at the start of the study most GPs
were not involved in insulin initiation, representatives of
specialists and GPs agreed (study groups) to limit the
role of GPs to a once-daily insulin regimen. For someGPs this compromise was a barrier to engage in the pro-
gram. They perceived the restriction as an indication
that specialists were not willing to share insulin therapy
with primary care.
Protocol adherence
Most GPs reported that the once-daily insulin regimen
was very practical to use. However most of them seldom
consulted the proposed protocol after the introduction
in the workshop. As a consequence, the DNE experi-
enced that some GPs did not respect the guidelines re-
garding insulin dose adjustment and SMBG control.
Some patients remained on an insufficient insulin dose
too long; others were shifted to a complex insulin scheme
too fast (questionnaire DNE; meeting reports). The risk
for hypoglycaemia remained a point of concern among
the majority of GPs. For this reason most GPs reported
asking patients to control glycaemic status more often
than advised in the protocol. According to the DNE this
approach risks to increase fear for hypoglycemia among
patients. The appropriate way to deal with this concern is
to provide adequate hypoglycaemia education (question-
naire DNE). Since a once-daily insulin regimen was barely
used in the region before the study started, specialists had
a learning curve too. They tended to handle the simple
regimen as a complex one, advising insulin (and oral
medication) dose adjustments on glucose curves instead
of on fasting blood glycaemia levels in the morning (meet-
ing reports).
Discussion
The study shows that the transition of insulin initiation
from secondary care to the primary care setting is a chal-
lenge. Although a support program addressing known
barriers to insulin initiation was provided, a substantial
number of GPs were reluctant to engage in this aspect of
care. The most striking differences between GPs engaged
and those not engaged in insulin initiation were observed
on the attitude towards the involvement in insulin ther-
apy, the perceived pressure to involve themselves in insu-
lin therapy and the perceived self-confidence. Overall, the
support provided in the program was evaluated in a posi-
tive way by users of the program (both by patients and
GPs). Most patients attending the program were able to
overcome barriers and appreciated being helped in the
primary care setting.
Implications for future program development
An interdisciplinary approach to role clarification
At the start of the study there was no clarity on the role
of GPs regarding insulin therapy. This can partly explain
the difference in attitude among GPs regarding their role
in insulin therapy initiation and in the perceived pres-
sure to engage themselves in insulin therapy. To
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in the initiation of a once-daily insulin regimen (in con-
sultation with the other care providers involved). The
problem of role ambiguity is not limited to our context
[22]. What makes the problem more prominent in our
study is the hesitation of health policy leaders to
reinforce the role of GPs in the health care system [10].
The study was conducted in a context where many GPs
felt insecure and frustrated about their role in health
care. They felt somehow powerless as they could not
compete with the expertise and service delivered in sec-
ondary care [10]. This climate hampered the uptake of
insulin initiation therapy among GPs. Further, the trad-
ition of interprofessional collaboration was still limited.
Our study was one of the first in the region to start a
process that led to an interdisciplinary care protocol and
as such contributed to a collaborative way of working
[10].
A dynamic approach to integration of expertise in primary
care
During the first year of the study 80 patients in the re-
gion received a first prescription for insulin therapy, 20
of whom attended the support program in primary care
(unpublished data). Given the relatively small and mostly
single-handed practices in Belgium (GP to population rate
of 1:925) the number of patients starting insulin therapy
(one patient per GP during the period of one year on aver-
age) limits the possibility for GPs to gain confidence.
However, as observed in our study, the collaboration with
an experienced DNE and the opportunity to receive feed-
back by specialists can reassure GPs to engage in this as-
pect of care and to gain confidence over time. As such the
DNE is likely to be pivotal for a successful shift of insulin
initiation to the primary care setting. In our study, support
was provided by a DNE operating in a community dia-
betes centre. She was in charge of all patients starting in-
sulin therapy in the program and gained confidence and
expertise when her case load gradually increased. By con-
sequence, her role extended to an expert role.
During the study period the DNE was coached by a spe-
cialist and further collaboration with specialists was soli-
cited in the future (explicitly asked by the DNE). This
raises questions on responsibilities when insulin therapy is
initiated in the primary care setting. Who is responsible
for the DNE: the GP by which the patient is referred or
the specialist (coach)? What are the responsibilities of the
DNE? Similar questions were raised in a recent study in
Australia [23]. Our study suggests that clarifying responsi-
bilities requires a dynamic approach with the emphasis on
what the patient needs rather than on organizational
boundaries [24]. For example, according to the protocol
patients had to break up their relationship with the DNE
in primary care once they required a more complexinsulin scheme. This was in contrast with the perspective
of continuity and the patients’ preference.
A dynamic approach should result in shared responsi-
bilities that can vary in function of the complexity of the
case, the experience of the individual GP and the avail-
able support in practice.
Feedback on protocol adherence
The importance of protocol adherence for the effective-
ness of the proposed insulin regimen became apparent
in the course of the study. The DNE reported problems
in relation to the adjustment of insulin doses and SMBG
control in several cases. The delegation of some tasks of the
protocol to the patient or the DNE is probably the most
suitable solution for this problem [25]. Data from clinical
trials show that a patient-directed approach to insulin dose
titration is a safe and effective alternative to a physician-
directed approach [26]. Further, fear of hypoglycaemia was
an important reason to deviate from the protocol among
patients and GPs. The DNE emphasized that the most im-
portant way to handle the problem of hypoglycaemia is re-
peated education, which should empower patients to deal
with the problem.
Comparison with existing literature
The literature reports extensively on barriers to insulin
therapy among patients and care providers [12-15]. Our
study evaluates a program supporting the transition of
insulin initiation to the primary care setting. To our
knowledge research on this subject is scarce.
Our findings are consistent with the literature on care
innovation [27]. As most GPs were used to refer their pa-
tients to secondary care, GPs were asked to change their
routines. Changing routines takes time and needs repeated
efforts, targeting different levels of the adoption process
[28]. A recent study evaluating a support program utiliz-
ing diabetes experts and community retail pharmacists to
enhance insulin prescribing in family practice came to the
same conclusion [29].
Our study also confirms literature findings about pa-
tient barriers towards insulin therapy. Patients are still
trying to postpone insulin therapy as long as possible.
Overcoming GP barriers to insulin initiation is a pre-
requisite to tackle reluctance among patients [30]. In
our study GPs experienced that gaining more confidence
in insulin therapy had also a positive effect on patients’
perception of insulin therapy.
Strengths and limitations of the study
An important strength of our study is that we were able
to include findings not only about GPs intending to
engage, but also about those who were not. The group
of non-participants is often not represented in evalu-
ation studies. The use of a well-established
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led to a deeper insight into factors that influence engage-
ment of GPs in insulin initiation. The triangulation of
findings from different viewpoints (patients, GPs,
DNE, specialist) contributes to the internal validity of
the findings regarding the program evaluation. How-
ever, the findings on program evaluation are only
representing the view of users of the program. As
non-users had no experience with the program we
did not ask them questions about the content of the
program. Our study findings cannot claim
generalizability. However, we aimed for transferability
of the results by giving clear information regarding
the context and the setting in which the data were
collected and interpreted. The relevance of the study
results for the current Belgian situation is clear as it be-
came apparent that the engagement of GPs in insulin initi-
ation, as encouraged by the care pathway T2DM (a new
national initiative of the NIHDI started in September
2009), was not self-evident. Similar problems as during
our study occurred and the engagement of GPs appeared
to be a critical issue in the success of the pathway. As
such our study contributes to a more in-depth under-
standing of the factors influencing the engagement of
GPs in insulin initiation (research question 1) and
helps to adapt the support program by sharing les-
sons learned (research question 2). The relevance of the
findings for other settings will differ in relation to the
way insulin initiation is organized currently and in re-
lation to the strength of the primary care system. For
settings planning to involve primary care in insulin initi-
ation our findings will help to develop a support program
and to anticipate some of the barriers we experienced. As
our findings suggest one can expect that setting up such a
program will encounter less barriers in a primary health
care setting where the role of GPs is clearly defined, sup-
port staff is available and collaboration between primary
and secondary care is well established [31]. For settings
where support for insulin initiation is already provided in
primary care our findings can be of interest in exploring
why there is still a delay in starting up insulin therapy
when metabolic control is not adequate [32].
Conclusion
The study shows that the transition of insulin initiation
from secondary care to the primary care setting is a
challenge. Although a support program addressing
known barriers to insulin initiation was provided, a
substantial number of GPs were reluctant to engage in
this aspect of care. Important issues for future program
development are: an interdisciplinary approach to job
clarification, a dynamic approach to the integration of
expertise in primary care and feedback on protocol
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